Banque Transatlantique’s Insmed INSM Stock Holding History

Banque Transatlantique’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,708	Closed	-$533K	–	271
2025 Q3	$533K	Buy	+3,708	New	+$454K	0.01%	91

Other funds holding INSM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Banque Transatlantique's INSM Position: Q4 2025 in Review

Banque Transatlantique sold out of Insmed (INSM) in Q4 2025, closing a stake of 3,708 shares — an estimated $533K sold.

Banque Transatlantique first reported a position in INSM in Q3 2025 and held it in 1 quarter. The position peaked at $533K in Q3 2025. 678 funds tracked by Wall St. Rank hold INSM as of Q4 2025.

Banque Transatlantique reported no remaining Insmed position as of Q4 2025 after selling out during the quarter.
Banque Transatlantique sold 3,708 Insmed shares in Q4 2025, an estimated $533K.
Banque Transatlantique first reported a position in Insmed in Q3 2025 and held it in 1 quarter.
Banque Transatlantique's Insmed position peaked at $533K in Q3 2025.
678 funds tracked by Wall St. Rank held Insmed as of Q4 2025.

Based on Banque Transatlantique's 13F filing for Q4 2025, filed 13 Feb 2026.